| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Medical Malpractice > Malpractice Lawsuits are Devastating in Many Ways |
|
Top Adding - Malpractice Lawsuits are Devastating in Many Ways
There are many types of harmful medical mistakes and potential mistakes for which According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product malpractice suits, and threats of malpractice suits, represent virtually the onl ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in y control. The problem with lawsuits to correct these actions is that identificat lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ion is often random and incomplete, and frequently the suits respond to bad luck here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe rather than bad practice. The suits may do more harm than good in the following w d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ys: 1. Interfere with and even destroy trusting patient-physician relationships. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Physicians come to view patients as litigants. 2. Over ordering of invasiv easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e tests to prevent the long-shot, bad luck case. 3. Tendency to cover-up mi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically stakes to prevent lawsuits. 4. Increasing the cost of medicine by many obvi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ous ways. 5. Failure to distinguish truly bad physicians from those who wer ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi victims of bad luck, good physicians are lumped together with bad. We still can' ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a t tell which physicians are in need of discipline. I am sure many physician dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s do try very hard to practice good medicine and don't let the threat of malpract cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ice influence their practice. But this is the real world, and physicians are huma tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen n first. For some doctors, avoiding lawsuits is very important as lawsuits are de t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel astating in more ways than I can enumerate. And this is troubling. Unfortunately ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust , it's like democracy itself. Lawsuits are the worst system for controlling malpr y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products actice. Except for any other system that we have. I would like to see an honest a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ppraisal, free of hype and blame, that would benefit patients and the medical sys elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tem. We can do better, but first we have to recognize what works and what doesn't tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Resume Layouts ... The Hidden Pitfalls How To Make Money Selling On eBay Learn Forex: Important Concepts for New Traders
|